With export currently a major focus for British companies, Philip Chapper & Co has already identified and made significant strides in a diverse range of markets, including Burma, Vietnam, Lebanon, the Caribbean and the Middle-East.
This focused export strategy will also see attendance at some of the world's biggest healthcare exhibitions over the next 12 months, including Medica, Expopharm, Medexpo and Arab Health.
Managing Director Philip Chapper said: "Our export credentials have been built over a sustained period and we have developed a very strong international network - and it is now time to expand that network even further.
"Combining our in-depth knowledge of the medical market, international relations, legislative requirements, high levels of customer service and the ability to quickly source stock has made the decision to expand into new emerging markets a logical one."
About Philip Chapper & Co Ltd
Philip Chapper & Co Ltd is a leading pharmaceutical and medical equipment supplier.
The Watford-based company, owned by Managing Director Philip Chapper, has been successfully providing both branded and generic pharmaceuticals, over the counter medicines, hospital supplies and equipment to clients all over the world for more than 35 years.
The company is an international exporter of: Pharmaceuticals, Disposables, Surgical Instruments, Medical Equipment, Diagnostic Tests, Dental Sundries and Dental Laboratory Supplies and Veterinary Medicines.
The company acts for Bunzl Healthcare, Rosemont Pharmaceuticals, Flynn Pharma, Manx Pharmaceuticals and Sigma Tau.